Featured News

Newswire releases carried on Biotech Insider. Each originates with the issuing company or its agency and carries that issuer's own compensation disclosure; they are not Biotech Insider editorial output.

1. 

   Sep 3 · 08:55Market Watch

   AI in Drug Discovery Market Projected to Reach $8.52 Billion By 2030

2. 

   Sep 1 · 11:37Market Watch

   A Wave of Weight-Loss Drugs Is Quietly Creating a Multi-Billion-Dollar Opportunity That Aesthetic Medicine Is Racing to Capture

3. 

   Aug 19 · 13:10Market Watch

   The Grid Queue Runs Five Years. This Equipment Ships on a Truck.

4. 

   Aug 19 · 08:56Market Watch

   Most AI Drug Discovery Reads the Genetic Code. The Next Wave Is Learning to Read What the Code Actually Does.

5. 

   Aug 18 · 12:57Market Watch

   A New Category Is Forming in Medical Aesthetics. Independent Research Has Started Sizing It.

6. 

   Aug 18 · 09:10Market Watch

   The Biggest Winners Don't Compete in a Category. They Rewrite It. One Company Is Betting It Can Too.

7. 

   Aug 17 · 09:14Market Watch

   Whey Prices Just Spiked 50%. This Pea Processor Just Woke Up.

8. 

   Aug 12 · 09:15Market Watch

   The GLP-1 Boom Created a Tissue Gap Fillers Were Not Built For

9. 

   Aug 11 · 15:35Market Watch

   Cosmetic Surgery's Next Debate: Rebuild Tissue, Not Fill It

10. 

    Aug 10 · 09:10Market Watch

    AI Found an Influenza Target That Survives Viral Mutation

11. 

    Aug 5 · 10:25Market Watch

    A CEO With a Proven Track Record of Success in Growing and Scaling Biopharmaceutical Companies Just Appointed CEO at a Clinical-Stage Biotech, Months Before Its Pivotal Phase 3 Readout

12. 

    Aug 4 · 09:05Market Watch

    Every Few Decades, Aesthetics Gets a New Category. One Preclinical Company Thinks Its Extra Cellular Matrix Platform Could Create the Next One

13. 

    Jul 24 · 09:10Market Watch

    A Small AI Company Just Took the Stage at One of the Biggest Events in Computing, and It Points to Where Drug Discovery Is Headed

14. 

    Jul 23 · 09:05Market Watch

    An AI Biotech Just Reported a 46% Revenue Jump and Its First Recurring Platform Contracts, as Its Pivot Starts Showing Up in the Numbers

15. 

    Jul 21 · 09:00Market Watch

    A Depression Drug Just Cleared a Key Hurdle Early, and the Market for New Mental Health Treatments Keeps Widening

16. 

    Jul 21 · 09:00Market Watch

    A Diabetes Therapy Just Locked In Its Cell Supplier, and the Race to End Insulin Injections Is Heating Up

17. 

    Jul 17 · 08:50Market Watch

    Big Pharma Just Paid Up to $3.8 Billion for Psychedelic Medicine, and the Rest of the Sector Is Being Repriced in Real Time

18. 

    Jul 15 · 11:01Market Watch

    The GLP-1 Boom Created a $2 Billion Opening in Aesthetics. One Preclinical Biotech Is Building the Product to Fill It.

19. 

    Jul 15 · 08:45Market Watch

    A Weight-Loss Revolution Is Reshaping Bodies. This Preclinical Biotech Wants to Build What Comes Next

20. 

    Jul 15 · 08:45Market Watch

    As AI Rewrites Drug Discovery, This Bio-Native AI Company Just Joined the Russell 3000E, and Reports Earnings July 22

21. 

    Jul 9 · 08:16Market Watch

    One Formula, One Platform: Inside the Preclinical Milestone Behind Conexeu's Move Into Medical Aesthetics

22. 

    Jul 8 · 09:00Market Watch

    The Longevity Protein Race Reaches Manufacturing: One Microcap Just Completed A GMP Master Cell Bank For Its Anti-Aging Klotho Therapy

23. 

    Jul 6 · 11:40Market Watch

    AI Energy Pivot Complete: LIXTE Biotechnology Finishes Corporate Rebrand to NOMAD Power Solutions, Begins Trading Under Nasdaq: NMAD

24. 

    Jul 6 · 11:19Market Watch

    A Clinical-Stage Cancer Company Is Putting AI to Work at the Bench, Designing Its Next Generation of Tumor-Targeting Drugs